Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 189-198

  Mensenkamp, Arjen R ^a   Luyn, Marja J A Van ^g   Goor, Harry Van ^b   Bloks, Vincent ^g   Apostel, Frank ^c   Greeve, Jobst ^c   Hofker, Marten H ^d   Jong, Miek C ^f   Vlijmen, Bart J M Van ^f   Havekes, Louis M ^e,f   Kuipers, Folkert ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Center for Human and Clinical Genetics   (Netherlands)

^e Departments of Cardiology   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Groningen Univ Inst Drug E ^*

Author keywords

Electron microscopy; Lipoproteins; Liver; RNA editing; Steatosis; Transgenesis

Indexed keywords

APOLIPOPROTEIN E3; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ELECTRON MICROSCOPY; FATTY LIVER; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOGOLD STAINING; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOPROTEIN SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EDITING; STEATOSIS; TRANSGENIC MOUSE;

EID: 17144446374     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80359-1     Document Type: Article

References (24)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
2. Hofker MH, van Vlijmen BJ, Havekes LM. Transgenic mouse models to study the role of apoE in hyperlipidemia and atherosclerosis. Atherosclerosis. 137:1998;1-11.
3. Plump AS, Breslow JL. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr. 15:1995;495-518.
4. Kuipers F, van Ree JM, Hofker MH, Wolters H, In 't Veld G, Havinga R, et al. Altered lipid metabolism in apolipoprotein Edeficient mice does not affect cholesterol balance across the liver. Hepatology. 24:1996;241-247.
5. Kuipers F, Jong MC, Lin Y, van Eck M, Havinga R, Bloks V, et al. Impaired secretion of Very Low Density Lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J. Clin. Invest. 100:1997;2915-2922.
6. Van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen BJ, van der Boom H, et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 268:1993;10540-10545.
7. Van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, et al. Modulation of very low density lipoprotein production and clearance contributes to age- and gender-dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 97:1996;1184-1192.
8. Van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, et al. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 93:1994;1403-1410.
9. Leppanen P, Luoma JS, Hofker MH, Havekes LM, Yla-Herttuala S. Characterization of atherosclerotic lesions in apoE3-Leiden transgenic mice. Atherosclerosis. 136:1998;147-152.
10. Jong MC, Dahlmans VE, van Gorp PJ, Breuer ML, Mol MJ, van der Zee A, et al. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein Cl. Arterioscler Thromb Vasc Biol. 16:1996;934-940.
11. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M. Very fast ultracentrifugation and serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta. 1254:1995;77-88.
12. Li X, Grundy SM, Patel S. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48 relative to B-100-containing lipoproteins. J Lipid Res. 37:1996;210-220.
13. Greeve J, Jona VK, Chowdhury NR, Horwitz MS, Chowdhury JR. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits. J Lipid Res. 37:1996;2001-2017.
14. Greeve J, Altkemper I, Dieterich JH, Greten H, Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is refelected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res. 34:1993;1367-1383.
15. Hamilton RL, Wong JS, Guo LSS, Krisans S, Havel RJ. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J Lipid Res. 31:1990;1589-1603.
16. Van Luyn MJA, Khouw IMSL, van Wachem PB, Blaauw EH, Werkmeister JA. Modulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T cell-deficient rats. J Biomed Mater Res. 39:1998;398-406.
17. Jong MC, Dahlmans VEH, Van Gorp PJJ, Willems van Dijk K, Breuer ML, Hofker MH, et al. In the absence of the low density lipoprotein receptor, human apolipoprotein CI overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest. 98:1996;2259-2267.
18. Jong MC, Van Ree JH, Dahlmans VEH, Frants RR, Hofker MH, Havekes LM. Reduced very low density lipoprotein fractional catabolic rate in apolipoprotein CI-deficient mice. Biochem J. 321:1997;445-450.
19. Coussons PJ, Bourgeois CS, Wiggins D, Gibbons GF. Selective recruitment of apoB-48 for the assembly of VLDL in rat triacylglycerol-enriched hepatocytes. Arterioscler Thromb Vasc Biol. 16:1996;889-897.
20. Chen CM, Vogel T, Sturley SL, Deckelbaum RJ. pH-dependent apolipoprotein E aggregation: a potential mechanism to escape intracellular degradation. [abstract] Circulation. 96:1997;I-346.
21. Ji ZS, Fazio S, Lee YL, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem. 269:1994;2764-2772.
22. Shimano H, Namba Y, Ohsuga J, Kawamura M, Yamamoto K, Shimida M, et al. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J Clin Invest. 93:1994;2215-2223.
23. Fazio S, Yao Z. The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly. Arterioscler Thromb Vasc Biol. 15:1995;593-600.
24. Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Basis of Inherited Disease. Vol. II. 7th ed. 1995;2287-2324 McGraw-Hill, Inc. New York.